bioTheranostics is Now an In-Network Provider With Highmark Health Services for Its CancerTYPE ID® Molecular Test for Metastatic Cancer

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, is now an in-network provider with Highmark Health Services, and the company’s CancerTYPE ID® molecular cancer classification test may be eligible for Highmark members based on the member’s individual benefits. Pittsburgh-based Highmark is one of the largest health insurers in the United States and the fourth-largest Blue Cross and Blue Shield-affiliated company, operating health plans that serve 5.3 million members.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC